Skip to main content

Table 4 Hazard ratio (HR) for cardiac disease related events using a univariate Cox proportional analysis in the propensity score-matched cohort

From: Relationship between history of coronary heart disease at dialysis initiation and onset of events associated with heart disease: a propensity-matched analysis of a prospective cohort study

Variables

HR

95% CI

P value

CHD group (vs. no CHD group)

1.955

1.369ā€“2.793

<0.001

Age (/10Ā year)

1.065

0.884ā€“1.283

0.506

Female gender

0.866

0.574ā€“1.308

0.494

Diabetes Mellitus

1.781

1.201ā€“2.641

0.004

BMI

0.949

0.903ā€“0.997

0.036

SBP (/10Ā mmHg)

0.928

0.867ā€“0.993

0.030

DBP (/10Ā mmHg)

0.897

0.796ā€“1.012

0.078

eGFR

1.053

1.005ā€“1.104

0.030

Creatinine

0.924

0.860ā€“0.993

0.032

BUN

0.997

0.991ā€“1.003

0.365

Hemoglobin

1.080

0.962ā€“1.212

0.193

Albumin

0.976

0.726ā€“1.313

0.874

Uric acid

1.011

0.944ā€“1.082

0.756

Potassium

0.971

0.793ā€“1.189

0.776

Adjusted calcium

1.113

0.922ā€“1.343

0.265

Phosphorus

0.899

0.805ā€“1.004

0.059

LDL-cholesterol (/10Ā mg/dL)

0.954

0.897ā€“1.014

0.129

HDL-cholesterol (/10Ā mg/dL)

0.841

0.735ā€“0.961

0.011

Triglyceride

0.999

0.997ā€“1.002

0.669

CRP

1.022

0.981ā€“1.065

0.292

Use of ARBs or ACEIs

0.895

0.632ā€“1.268

0.532

Use of Ī²-blockers

1.465

1.034ā€“2.075

0.032

Use of anti-platelet agents

1.920

1.344ā€“2.743

<0.001

Use of loop diuretics

1.226

0.808ā€“1.861

0.339

Use of statins

1.756

1.183ā€“2.605

0.005

  1. HR hazard ratio, CI confidence interval, CHD coronary heart disease, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, eGFR estimated glomerular filtration rate, BUN blood urea nitrogen, LDL low density lipoprotein, HDL high density lipoprotein, CRP C-reactive protein, ARBs angiotensin receptor blockers